Saltar al contenido
Merck

Maternal first-trimester diet and childhood bone mass: the Generation R Study.

The American journal of clinical nutrition (2013-05-31)
Denise H M Heppe, Carolina Medina-Gomez, Albert Hofman, Oscar H Franco, Fernando Rivadeneira, Vincent W V Jaddoe
RESUMEN

Maternal diet during pregnancy has been suggested to influence bone health in later life. We assessed the association of maternal first-trimester dietary intake during pregnancy with childhood bone mass. In a prospective cohort study in 2819 mothers and their children, we measured first-trimester daily energy, protein, fat, carbohydrate, calcium, phosphorus, and magnesium intakes by using a food-frequency questionnaire and homocysteine, folate, and vitamin B-12 concentrations in venous blood. We measured childhood total body bone mass by using dual-energy X-ray absorptiometry at the median age of 6.0 y. Higher first-trimester maternal protein, calcium, and phosphorus intakes and vitamin B-12 concentrations were associated with higher childhood bone mass, whereas carbohydrate intake and homocysteine concentrations were associated with lower childhood bone mass (all P-trend < 0.01). Maternal fat, magnesium intake, and folate concentrations were not associated with childhood bone mass. In the fully adjusted regression model that included all dietary factors significantly associated with childhood bone mass, maternal phosphorus intake and homocysteine concentrations most-strongly predicted childhood bone mineral content (BMC) [β = 2.8 (95% CI: 1.1, 4.5) and β = -1.8 (95% CI: -3.6, 0.1) g per SD increase, respectively], whereas maternal protein intake and vitamin B-12 concentrations most strongly predicted BMC adjusted for bone area [β = 2.1 (95% CI: 0.7, 3.5) and β = 1.8 (95% CI: 0.4, 3.2) g per SD increase, respectively]. Maternal first-trimester dietary factors are associated with childhood bone mass, suggesting that fetal nutritional exposures may permanently influence bone development.

MATERIALES
Referencia del producto
Marca
Descripción del producto

Sigma-Aldrich
Vitamina B12, ≥98%
Sigma-Aldrich
Vitamina B12, BioReagent, suitable for cell culture, suitable for insect cell culture, suitable for plant cell culture, ≥98%
Sigma-Aldrich
Magnesio, powder, ≥99%
Supelco
Vitamina B12, pharmaceutical secondary standard, certified reference material
Supelco
Cianocobalamina (B12), analytical standard
Sigma-Aldrich
L-Homocysteine, ≥98.0% (NT)
Sigma-Aldrich
Magnesio, turnings, reagent grade, 98%
Sigma-Aldrich
Magnesio, purum, for Grignard reactions, ≥99.5%, turnings
Sigma-Aldrich
Magnesio, ribbon, ≥99.0% Mg basis
Sigma-Aldrich
Magnesio, chips, 6-35 mesh, 99.98% trace metals basis
Supelco
Vitamina B12, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®
Sigma-Aldrich
Magnesio, turnings, 5-25 mm, 99.95% trace metals basis
Sigma-Aldrich
Vitamina B12, meets USP testing specifications
Sigma-Aldrich
Magnesio, wire, 127 μm diameter, 99.9% trace metals basis
Sigma-Aldrich
Magnesium preparation, Highly Reactive Rieke® Metal, suspension, 2.5 g in THF
Sigma-Aldrich
Vitamina B12, tested according to Ph. Eur.
Sigma-Aldrich
Magnesio, dendritic pieces, purified by distillation, 99.998% trace metals basis
Sigma-Aldrich
Magnesio, 20-230 mesh, reagent grade, 98%
Sigma-Aldrich
Magnesio, grit, ≥99.0% (KT)
Sigma-Aldrich
Magnesio, rod, diam. 6 mm, ≥99.9% trace metals basis
Sigma-Aldrich
Magnesio, ReagentPlus®, ribbon, ≥99% trace metals basis
Sigma-Aldrich
Magnesio, in a Sure/Seal bottle, turnings, 37.5 mmol
Sigma-Aldrich
Magnesio, in a Sure/Seal bottle, turnings, anhydrous tetrahydrofuran 37.5 mmol